Skip to main content
. 2021 Sep 7;18(9):e1003766. doi: 10.1371/journal.pmed.1003766

Fig 3. Change in corrected QT interval after antimalarial treatment for uncomplicated malaria.

Fig 3

Change in QT interval adjusted with study-specific heart rate correction (QTcS) after treatment with the antimalarials artesunate-amodiaquine (ASAQ), chloroquine (CQ), dihydroartemisinin-piperaquine (DP), artemether-lumefantrine (AL), and pyronaridine-artesunate (PyAS) from a multivariable linear mixed effects regression model adjusting for age group, sex, body temperature, and individual study/site/person effects. Lines indicate means with colour representing antimalarial treatment arm, shaded areas denote 95% confidence intervals, and dots are partial residuals.